Latest News about ANIP
Recent news which mentions ANIP
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
October 11, 2024
From Benzinga
In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
September 17, 2024
Tickers
ANIP
From Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
From Benzinga
Tickers
ANIP
From InvestorPlace
From Benzinga
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
June 25, 2024
From Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
June 24, 2024
From InvestorPlace
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
June 24, 2024
From Benzinga
Tickers
ANIP
From InvestorPlace
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
March 11, 2024
From Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
From Benzinga
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
February 16, 2024
Tickers
ANIP
From Benzinga
What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
August 21, 2023
Tickers
ANIP
From Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
August 17, 2023
Tags
NASDAQ:ANIP,NASDAQ:IMGN,NASDAQ:WVE,NASDAQ:ELVN,NASDAQ:NUVL,NASDAQ:LLY,NYSE:NVO
Market News
IMGN
From InvestorPlace
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 08, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.